10 challenges for businesses in APAC
India | Analysis | By BioSpectrum Bureau | 0 Comment | 17 May, 2012
The Asia Pacific healthcare market is estimated to capture 34.6 percent of the global healthcare market by 2015. Frost &...Read more
Avesthagen to earn $30 mn in 10 years from AvestaDHA
India | News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2013
New Delhi: Avesthagen entered into a license agreement with a leading specialty chemicals company for its 100 percent ve...Read more
Sun Pharma revenue touches $480 million in Q2 2012
India | Company results | By BioSpectrum Bureau | 8 Comment | 10 Aug, 2012
Mumbai: Sun Pharmaceutical Industries reported a growth of 62 percent in its net sales for the quarter ending June 30, 2...Read more
India clears 12 FDI proposals worth $58 mn
India | News | By BioSpectrum Bureau | 0 Comment | 07 Aug, 2013
New Delhi: The Indian government has cleared 12 foreign direct investment (FDI) proposals worth $58.13 million. However...Read more
Kemwell gets FDA nod after cGMP audit
India | Regulatory | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2013
Bangalore: Kemwell Biopharma's oral solids manufacturing facility located in Bangalore, India, has successfully complete...Read more
Netherlands' IMCD acquires India's Indchem
India | News | By BioSpectrum Bureau | 0 Comment | 20 Feb, 2013
Singapore: Netherlands-based IMCD has acquired India's Indchem International. The business of Mumbai-based Indchem has a...Read more
Caraco closes tender offer to acquire DUSA
India | News | By BioSpectrum Bureau | 0 Comment | 21 Dec, 2012
Mumbai: Caraco Pharma subsidiary, Caraco Acquisition, highlighted that its tender offer to acquire all of the outstandin...Read more
BioSpectrum Asia honors Asia's best in bioscience
India | News | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2013
Singapore: The fifth BioSpectrum Asia Pacific Awards 2013 were given away at a glittering ceremony at Hotel Fort Canning...Read more
What is the revenue size, range of CROs in APAC?
India | Analysis | By BioSpectrum Bureau | 2 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
FIPB clears seven pharma proposals, defers three
India | Regulatory | By BioSpectrum Bureau | 3 Comment | 08 Jul, 2013
Singapore: The Foreign Investment Promotion Board (FIPB) has cleared seven out of the ten investment proposals in the ph...Read more
Generics market to touch $231 bn by 2017: Report
India | Analysis | By BioSpectrum Bureau | 2 Comment | 04 Jun, 2012
Singapore: The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to t...Read more
India, China to appeal against EU regulation on API
India | News | By BioSpectrum Bureau | 0 Comment | 10 Aug, 2012
Bangalore: Following a change in rules for importing active substances into the European Union for medicinal products fo...Read more
Xenetic recruits patients for anemia drug trial in India
India | News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2013
Singapore: UK-based biopharma company, Xenetic Biosciences, said in a statement that the recruitment process for the tri...Read more
India's regulatory framework needs lot more work
India | Analysis | By BioSpectrum Bureau | 2 Comment | 05 Sep, 2013
Everything does not seem to be well in the pharmaceutical industry of Asia's third largest economy - India. Although the...Read more
India's Jubilant receives FDA warning for US plant
India | News | By BioSpectrum Bureau | 0 Comment | 06 Dec, 2013
Singapore: Jubilant Life Sciences has joined the list of leading Indian drug makers who have received a warning from the...Read more
Thumbs down to report recommending GM trial ban
India | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2012
Bangalore: Eminent biotechnologists, agricultural scientists and heads of agribiotech industry came together on Saturday...Read more
Start-ups redefining the industry
India | News | By BioSpectrum Bureau | 0 Comment | 30 May, 2012
Life sciences industry in the Asia Pacific recorded the double digit growth of 16.6 percent, reaching $128.26 billion in...Read more
India-made prostate cancer drug files for IND with FDA
India | News | By BioSpectrum Bureau | 0 Comment | 07 Aug, 2013
Bangalore: A new drug to treat prostate cancer, which was developed by Bangalore-based Jubilant Biosys and US-based coll...Read more